150 related articles for article (PubMed ID: 19656221)
1. Clinical assessment of topiramate therapy in patients with migrainous vertigo.
Gode S; Celebisoy N; Kirazli T; Akyuz A; Bilgen C; Karapolat H; Sirin H; Gokcay F
Headache; 2010 Jan; 50(1):77-84. PubMed ID: 19656221
[TBL] [Abstract][Full Text] [Related]
2. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
Silberstein S; Lipton R; Dodick D; Freitag F; Mathew N; Brandes J; Bigal M; Ascher S; Morein J; Wright P; Greenberg S; Hulihan J
Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
[TBL] [Abstract][Full Text] [Related]
4. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
5. Zonisamide versus topiramate in migraine prophylaxis: a double-blind randomized clinical trial.
Mohammadianinejad SE; Abbasi V; Sajedi SA; Majdinasab N; Abdollahi F; Hajmanouchehri R; Faraji A
Clin Neuropharmacol; 2011; 34(4):174-7. PubMed ID: 21738025
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis.
Ashtari F; Shaygannejad V; Akbari M
Acta Neurol Scand; 2008 Nov; 118(5):301-5. PubMed ID: 18713156
[TBL] [Abstract][Full Text] [Related]
7. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
[TBL] [Abstract][Full Text] [Related]
8. Zonisamide for migraine prophylaxis in patients refractory to topiramate.
Bermejo PE; Dorado R
Clin Neuropharmacol; 2009; 32(2):103-6. PubMed ID: 18978487
[TBL] [Abstract][Full Text] [Related]
9. Topiramate in migraine prevention: results of a large controlled trial.
Silberstein SD; Neto W; Schmitt J; Jacobs D;
Arch Neurol; 2004 Apr; 61(4):490-5. PubMed ID: 15096395
[TBL] [Abstract][Full Text] [Related]
10. Topiramate vs divalproex sodium in the preventive treatment of migraine: a prospective "real-world" study.
Krymchantowski AV; Jevoux CC
Headache; 2011 Apr; 51(4):554-8. PubMed ID: 21457240
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of the effects of low-dose topiramate versus sodium valproate in migraine prophylaxis.
Afshari D; Rafizadeh S; Rezaei M
Int J Neurosci; 2012 Feb; 122(2):60-8. PubMed ID: 21950578
[TBL] [Abstract][Full Text] [Related]
12. Low-dose topiramate versus lamotrigine in migraine prophylaxis (the Lotolamp study).
Gupta P; Singh S; Goyal V; Shukla G; Behari M
Headache; 2007 Mar; 47(3):402-12. PubMed ID: 17371357
[TBL] [Abstract][Full Text] [Related]
13. A randomized, one-year clinical trial comparing the efficacy of topiramate, flunarizine, and a combination of flunarizine and topiramate in migraine prophylaxis.
Luo N; Di W; Zhang A; Wang Y; Ding M; Qi W; Zhu Y; Massing MW; Fang Y
Pain Med; 2012 Jan; 13(1):80-6. PubMed ID: 22233396
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of topiramate in the treatment of pediatric chronic daily headache.
Borzy JC; Koch TK; Schimschock JR
Pediatr Neurol; 2005 Nov; 33(5):314-6. PubMed ID: 16243217
[TBL] [Abstract][Full Text] [Related]
15. Topiramate for migraine prevention in a naturalistic setting: results from an open label, flexible dose study.
Nelles G; Delbrück A; Schulze L; Kademann B; Bornhoevd K; Schäfer S; Schäuble B;
Headache; 2009; 49(10):1454-65. PubMed ID: 19804392
[TBL] [Abstract][Full Text] [Related]
16. The impact of topiramate on health-related quality of life indicators in chronic migraine.
Dodick DW; Silberstein S; Saper J; Freitag FG; Cady RK; Rapoport AM; Mathew NT; Hulihan J; Crivera C; Rupnow MF; Mao L; Finlayson G; Greenberg SJ
Headache; 2007; 47(10):1398-408. PubMed ID: 18052949
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effect of topiramate and sodium valporate in migraine prevention: a randomized blinded crossover study.
Shaygannejad V; Janghorbani M; Ghorbani A; Ashtary F; Zakizade N; Nasr V
Headache; 2006 Apr; 46(4):642-8. PubMed ID: 16643559
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of topiramate in migraine prophylaxis: an open controlled randomized study comparing Sincronil and topamax formulations.
Cosentino G; Paladino P; Maccora S; Indovino S; Fierro B; Brighina F
Panminerva Med; 2013 Sep; 55(3):303-7. PubMed ID: 24088805
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, dose comparison study of topiramate for prophylaxis of basilar-type migraine in children: a pilot study.
Lewis D; Paradiso E
Headache; 2007; 47(10):1409-17. PubMed ID: 18052950
[TBL] [Abstract][Full Text] [Related]
20. Randomized dose-controlled study of topiramate as first-line therapy in epilepsy.
Arroyo S; Dodson WE; Privitera MD; Glauser TA; Naritoku DK; Dlugos DJ; Wang S; Schwabe SK; Twyman RE;
Acta Neurol Scand; 2005 Oct; 112(4):214-22. PubMed ID: 16146489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
